Duckhorn's Q2 results were mixed with lower than expected revenue and declining sales volumes. Lowered full-year guidance and YoY revenue decline may concern investors, but robust gross margins and strong cost management are positive signs.
Insider selling at Duckhorn Portfolio, including a recent sale by Pete Przybylinski at around the current price of US$9.61, is a negative sign. Despite the company's profitability and growth, this activity warrants careful consideration before investing.
Constellation Brands had a weak quarter with underwhelming earnings guidance. Duckhorn showed the slowest revenue growth and weakest full-year guidance. Boston Beer and Zevia PBC had mixed quarters with misses and beats on various estimates.
Despite insider buying, investment in the last three months is deemed insignificant. Ongoing analysis displays caution towards the company's transactions, mainly consisting of selling.
Bank of America analyst Peter Galbo downgraded the stock from 'Buy' to 'Neutral' and reduced the price target from $15 to $11. He suggests that the long-term benefits of the Sonoma-Cutrer Vineyards acquisition might outweigh the short-term dilution effect.
Though Duckhorn's gross margin surpassed expectations, it fell short on revenue, operating margin, and EPS because of a big sales volume drop-off. Its strong financial position, characterized by over $21.18 million cash reserves and near breakeven free cash flow margins, can't hide the fact that the stock slipped by 4% following mixed quarterly results.
$マイクロン テクノロジー(MU.US)$ — The chip stock slid 4% in extended trading after Micron offered weaker-than-expected earnings guidance for the current quarter. Micron said to expect a loss of $1.07 per share, while analysts polled by LSEG, formerly known as Refinitiv, expected 95 cents. Elsewhere, the company posted a narrower-than-expected loss for the fiscal fourth quarter, as well as revenue that came in ahead of expectations. Current-quarter revenue ...
Gainers: •$ベル(VERU.US)$+11.4% (extends momentum from +13% move during regular session) •$アノビス・バイオ(ANVS.US)$+9.4% (received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed) •$ゲームストップ(GME.US)$+6.7% (announces 4-for-l stock split) •$Bed Bath & Beyond Inc(BBBY.US)$+6% (interim CEO purchases 50000 shares) •$バールコ・エナジー(EGY.US)$+5.4% (completes South Tchibala 1HB-ST W...
Gainers: •$オクタ(OKTA.US)$+15.8% (In reaction to earnings) •$ストーン(STNE.US)$+12.9% (In reaction to earnings) •$ターニング・ポイント・セラピューティクス(TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$アミリックス・ファーマシューティカルズ(AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
ダックホーン・ポートフォリオに関するコメント
Stocks making the biggest moves after hours:
— The chip stock slid 4% in extended trading after Micron offered weaker-than-expected earnings guidance for the current quarter. Micron said to expect a loss of $1.07 per share, while analysts polled by LSEG, formerly known as Refinitiv, expected 95 cents. Elsewhere, the company posted a narrower-than-expected loss for the fiscal fourth quarter, as well as revenue that came in ahead of expectations. Current-quarter revenue ...
コラムToday's Pre-Market Stock Movers: KMX, RAD, BBBY, MTN and More
In reaction to earnings/guidance:
• $ベイル・リゾーツ(MTN.US)$ +3.7%,$ダックホーン・ポートフォリオ(NAPA.US)$ +2.7%,$ジェフリーズ・ファイナンシャル・グループ(JEF.US)$ +1.6%
Other news:
• $アクサム・セラピューティクス(AXSM.US)$ +4.3% (disclosesplansto resubmit AXS-07 NDA basedonsuccessfulFDAtype a meeting)
• $インビビッド(IVVD.US)$ +4.1% (files for $400mlnmixed securities shelf offering)
• $トリチウムDCFC(DCFC.US)$ +3.1%(tosupply fast chargers for Australia's l...
コラムToday's pre-market stock movers: SPCE, GME, BBBY, SHEL and more
• $ベル(VERU.US)$ +11.4% (extends momentum from +13% move during regular session)
• $アノビス・バイオ(ANVS.US)$ +9.4% (received notice from the FDA that the Phase 3 clinical study in early Parkinson's patients may proceed)
• $ゲームストップ(GME.US)$ +6.7% (announces 4-for-l stock split)
• $Bed Bath & Beyond Inc(BBBY.US)$ +6% (interim CEO purchases 50000 shares)
• $バールコ・エナジー(EGY.US)$ +5.4% (completes South Tchibala 1HB-ST W...
コラムToday's pre-market stock movers: TSLA, CHGG, OKTA, TPTX and more
• $オクタ(OKTA.US)$ +15.8% (In reaction to earnings)
• $ストーン(STNE.US)$ +12.9% (In reaction to earnings)
• $ターニング・ポイント・セラピューティクス(TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $アミリックス・ファーマシューティカルズ(AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
まだコメントはありません